🎉 M&A multiples are live!
Check it out!

OptimizeRx Valuation Multiples

Discover revenue and EBITDA valuation multiples for OptimizeRx and similar public comparables like Echo IQ, Doctor Care Anywhere, and CurveBeam AI.

OptimizeRx Overview

About OptimizeRx

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.


Founded

2006

HQ

United States of America
Employees

129

Website

optimizerx.com

Financials

LTM Revenue $94.8M

LTM EBITDA $11.9M

EV

$174M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

OptimizeRx Financials

OptimizeRx has a last 12-month revenue of $94.8M and a last 12-month EBITDA of $11.9M.

In the most recent fiscal year, OptimizeRx achieved revenue of $92.1M and an EBITDA of -$8.9M.

OptimizeRx expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See OptimizeRx valuation multiples based on analyst estimates

OptimizeRx P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $71.5M $92.1M XXX XXX XXX
Gross Profit $39.0M $42.9M XXX XXX XXX
Gross Margin 54% 47% XXX XXX XXX
EBITDA -$21.3M -$8.9M XXX XXX XXX
EBITDA Margin -30% -10% XXX XXX XXX
Net Profit -$11.4M -$17.6M XXX XXX XXX
Net Margin -16% -19% XXX XXX XXX
Net Debt n/a $22.4M XXX XXX XXX

Financial data powered by Morningstar, Inc.

OptimizeRx Stock Performance

As of April 15, 2025, OptimizeRx's stock price is $8.

OptimizeRx has current market cap of $154M, and EV of $174M.

See OptimizeRx trading valuation data

OptimizeRx Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$174M $154M XXX XXX XXX XXX $0.35

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

OptimizeRx Valuation Multiples

As of April 15, 2025, OptimizeRx has market cap of $154M and EV of $174M.

OptimizeRx's trades at 1.8x LTM EV/Revenue multiple, and 14.6x LTM EBITDA.

Analysts estimate OptimizeRx's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for OptimizeRx and 10K+ public comps

OptimizeRx Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $174M XXX XXX XXX
EV/Revenue 1.9x XXX XXX XXX
EV/EBITDA -19.5x XXX XXX XXX
P/E -7.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 39.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get OptimizeRx Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

OptimizeRx Valuation Multiples

OptimizeRx's NTM/LTM revenue growth is 10%

OptimizeRx's revenue per employee for the last fiscal year averaged $0.7M, while opex per employee averaged $0.5M for the same period.

Over next 12 months, OptimizeRx's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate OptimizeRx's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for OptimizeRx and other 10K+ public comps

OptimizeRx Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 29% XXX XXX XXX XXX
EBITDA Margin -10% XXX XXX XXX XXX
EBITDA Growth -58% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 1% XXX XXX XXX XXX
Revenue per Employee $0.7M XXX XXX XXX XXX
Opex per Employee $0.5M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 67% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 71% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

OptimizeRx Public Comps

See public comps and valuation multiples for Healthcare Software and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Benevolent AI XXX XXX XXX XXX XXX XXX
Alcidion Group XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Doctor Care Anywhere XXX XXX XXX XXX XXX XXX
Echo IQ XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

OptimizeRx M&A and Investment Activity

OptimizeRx acquired  XXX companies to date.

Last acquisition by OptimizeRx was  XXXXXXXX, XXXXX XXXXX XXXXXX . OptimizeRx acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by OptimizeRx

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About OptimizeRx

When was OptimizeRx founded? OptimizeRx was founded in 2006.
Where is OptimizeRx headquartered? OptimizeRx is headquartered in United States of America.
How many employees does OptimizeRx have? As of today, OptimizeRx has 129 employees.
Who is the CEO of OptimizeRx? OptimizeRx's CEO is Mr. Stephen L. Silvestro.
Is OptimizeRx publicy listed? Yes, OptimizeRx is a public company listed on NAS.
What is the stock symbol of OptimizeRx? OptimizeRx trades under OPRX ticker.
When did OptimizeRx go public? OptimizeRx went public in 2009.
Who are competitors of OptimizeRx? Similar companies to OptimizeRx include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere.
What is the current market cap of OptimizeRx? OptimizeRx's current market cap is $154M
What is the current revenue of OptimizeRx? OptimizeRx's last 12-month revenue is $94.8M.
What is the current EBITDA of OptimizeRx? OptimizeRx's last 12-month EBITDA is $11.9M.
What is the current EV/Revenue multiple of OptimizeRx? Current revenue multiple of OptimizeRx is 1.8x.
What is the current EV/EBITDA multiple of OptimizeRx? Current EBITDA multiple of OptimizeRx is 14.6x.
What is the current revenue growth of OptimizeRx? OptimizeRx revenue growth between 2023 and 2024 was 29%.
Is OptimizeRx profitable? Yes, OptimizeRx is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.